UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Integrin αIIb-mediated PI3K/Akt activation in platelets

PloS one, 2012-10, Vol.7 (10), p.e47356-e47356

2012

Volltextzugriff (PDF)

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

The New England journal of medicine, 2009-01, Vol.360 (5), p.544-546

2009

Volltextzugriff (PDF)

Atypical Hemolytic Uremic Syndrome

The Pediatric clinics of North America, 2018-06, Vol.65 (3), p.509-525

2018

Volltextzugriff (PDF)

Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis

Pediatric radiology, 2015-04, Vol.45 (5), p.719-726

2015

Volltextzugriff (PDF)

Treatment of hemophilia in developing countries: A journey of a thousand miles

Pediatric blood & cancer, 2010-03, Vol.54 (3), p.348-349

Gruppo, Ralph A.

2010

Volltextzugriff (PDF)

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-01, Vol.327 (2), p.129

2022

Volltextzugriff (PDF)

Legg-Calve-Perthes disease and thrombophilia

Journal of bone and joint surgery. American volume, 2004-12, Vol.86 (12), p.2642

2004

Volltextzugriff (PDF)

The β3 subunit of the integrin αIIbβ3 regulates αIIb-mediated outside-in signaling

Blood, 2005-06, Vol.105 (11), p.4345-4352

2005

Volltextzugriff (PDF)

The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults

Thrombosis and haemostasis, 1999-05, Vol.81 (5), p.739

1999

Volltextzugriff (PDF)

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Blood, 2013-02, Vol.121 (8), p.1446-1454

2013

Volltextzugriff (PDF)

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.354-360

2016

Volltextzugriff (PDF)

Abnormally sialylated fibrinogen γ-chains in a patient with chronic thromboembolic pulmonary hypertension

Thrombosis research, 2007-01, Vol.119 (2), p.257-259

2007

Volltextzugriff (PDF)

Ventilation-Perfusion Scintigraphy in Children and Adolescents Is Associated With a Low Rate of Indeterminate Studies

Clinical nuclear medicine, 2008-09, Vol.33 (9), p.606-609

2008

Volltextzugriff (PDF)

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma

Pediatric Blood & Cancer, 2007-04, Vol.48 (4), p.479-482

2007

Volltextzugriff (PDF)

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.113-118

2013

Volltextzugriff (PDF)

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

Blood, 2017-12, Vol.130, p.1048-1048

2017

Volltextzugriff (PDF)

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.913

2012

Volltextzugriff (PDF)

Long-Term Outcome in a Pediatric Patient with Atypical Hemolytic Uremic Syndrome (aHUS) with Sustained Eculizumab (ECU) Treatment

Blood, 2011-11, Vol.118 (21), p.4682-4682

2011

Volltextzugriff (PDF)

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Blood, 2018-11, Vol.132 (Supplement 1), p.3774-3774

2018

Volltextzugriff (PDF)

Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (3), p.354-361

2014

Volltextzugriff (PDF)

Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease

Journal of pediatric hematology/oncology, 2002-06, Vol.24 (5), p.374-379

2002

Volltextzugriff (PDF)

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Blood, 2015-12, Vol.126 (23), p.2299-2299

2015

Volltextzugriff (PDF)

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

Blood, 2016-12, Vol.128 (22), p.328-328

2016

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(81)
Berichte
(1)

Sprache

Englisch
(82)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrin αIIb-mediated PI3K/Akt activation in platelets

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

Atypical Hemolytic Uremic Syndrome

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis

Treatment of hemophilia in developing countries: A journey of a thousand miles

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial

Legg-Calve-Perthes disease and thrombophilia

The β3 subunit of the integrin αIIbβ3 regulates αIIb-mediated outside-in signaling

The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Abnormally sialylated fibrinogen γ-chains in a patient with chronic thromboembolic pulmonary hypertension

Ventilation-Perfusion Scintigraphy in Children and Adolescents Is Associated With a Low Rate of Indeterminate Studies

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

Long-Term Outcome in a Pediatric Patient with Atypical Hemolytic Uremic Syndrome (aHUS) with Sustained Eculizumab (ECU) Treatment

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study

Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

Suchergebnisse filtern